Home/Pipeline/Zonisamide OD Tablets

Zonisamide OD Tablets

Epilepsy

ApprovedCommercial

Key Facts

Indication

Epilepsy

Phase

Approved

Status

Commercial

Company

Kotobuki Pharmaceutical

About Kotobuki Pharmaceutical

A Japanese pharmaceutical company focused on manufacturing and developing small molecule drugs in gastroenterology, oncology, and neurology, with expertise in formulation development.

View full company profile

Therapeutic Areas

Oncology Gastroenterology Neurology Metabolic Disease Pain

Other Epilepsy Drugs

Drug	Company	Phase	Status
ADX71149 (mGlu2 PAM)	Addex Therapeutics	Phase 2	Active (with Janssen)
TRV045	Trevena	Phase 1	Active
SAGE-324	Sage Therapeutics	Preclinical	Research
Motpoly XR™	Aucta Pharmaceuticals	Not Specified (Likely Phase 3/NDA)	Active
ADB-104	Adolore BioTherapeutics	Pre-clinical	Active
Not Publicly Disclosed	Cerecin	Phase 2	Active
eTNS Platform	NeuroSigma	Unknown	Active
NPT 2042	NeuroPro Therapeutics	Phase 2	Active
Spritam (levetiracetam)	Aprecia Pharmaceuticals	Approved	Active
Perampanel	Ark Diagnostics	In Development	Active
NeuroAccess Platform	Cordance Medical	Pre-clinical/Research	Active
Epilepsy Program	Current Surgical	Research	Active